JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Incidence of individualized training on exercise-induced desaturation in COPD patients].

BACKGROUND: Exercise-induced desaturation is a well-described phenomenon in COPD patients during exercise assessments such as the six minute walk test (6MWT). Some of the pathophysiological mechanisms involved in this O2 desaturation could be modified by individualized exercise training as part of a pulmonary rehabilitation programme. The aim of this study was to determine the effect of pulmonary rehabilitation on O2 desaturation exhibited by COPD patients during a 6MWT.

METHODS: Twenty COPD patients (FEV1=61.1 +/- 3.2% predicted) who exhibited O2 desaturation before rehabilitation (mean 7.3 +/- 0.7% with a mean duration of 5.3 +/- 0.1 min) participated. They performed four weeks of RP including individualized whole-body exercise training achieving a mean 9.3 +/- 0.27 hours per week of exercise tailored to their ventilatory threshold.

RESULTS: Dyspnoea at the end of the test, ventilatory threshold and FEV1 were retained as correlates of desaturation before rehabilitation. After rehabilitation, 6MWT distance increased (p<0.01) with reduced dyspnoea (p<0.05). Two sub-groups were identified: persistent desaturaters (DS, n=13) and non-desaturaters group (NDS, n=7). There were no baseline differences between the two groups. After rehabilitation only the persistent desaturaters showed a significant increase in distance achieved during 6MWT associated with a reduced dyspnea (p<0.05). This group showed a mean O2 desaturation equal to 8.1 +/- 0.9% which persisted to 5 +/- 0.3 min. A tendency to a lower dyspnoea at the end of 6MWT performed before rehabilitation was observed in NDS compared with DS (p<0.058).

CONCLUSION: It seems that responses to a pulmonary rehabilitation programme including individualized exercise training could act on O2 desaturation. Indeed 7 of 20 (35%) COPD patients exhibiting O2 desaturation during a 6MWT showed no O2 desaturation after rehabilitation programme while 13 on 20 (65%) do it.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app